Similar articles

• Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events.

  Saag KG, Koehnke R, Caldwell JR, Brasington R, Burmeister LF, Zimmerman B, Kohler JA, Furst DE. Saag KG, et al. Am J Med. 1994 Feb;96(2):115-23. doi: 10.1016/0002-9343(94)90131-7. Am J Med. 1994. PMID: 8109596
• Are long-term very low doses of prednisone for patients with rheumatoid arthritis as helpful as high doses are harmful?

  Pincus T, Sokka T, Stein CM. Pincus T, et al. Ann Intern Med. 2002 Jan 1;136(1):76-8. doi: 10.7326/0003-4819-136-1-200201010-00013. Ann Intern Med. 2002. PMID: 11777366 No abstract available.
• Dangers of low-dose corticosteroid therapy in rheumatoid arthritis.

  Ramos-Remus C, Russell AS. Ramos-Remus C, et al. Bull Rheum Dis. 1997 Jun;46(4):1-4. Bull Rheum Dis. 1997. PMID: 9188202 Review.
• New role for an old friend: prednisone is a disease-modifying agent in early rheumatoid arthritis.

  Conn DL, Lim SS. Conn DL, et al. Curr Opin Rheumatol. 2003 May;15(3):193-6. doi: 10.1097/00002281-200305000-00004. Curr Opin Rheumatol. 2003. PMID: 12707570 Review.
• Glucocorticoid use in rheumatoid arthritis.

  Harris ED Jr. Harris ED Jr. Hosp Pract (Off Ed). 1983 Sep;18(9):137-41, 145-6. doi: 10.1080/21548331.1983.11702634. Hosp Pract (Off Ed). 1983. PMID: 6411587